Article révisé par les pairs
Résumé : Bleomycin appears to be a useful drug to add to the therapeutic arsenal for the treatment of mycosis fungoides and reticulum cell lymphoma. Because of this drug's absence of hematological toxicity and the short duration of the remissions, we suggest its association with other cytostatics in the treatment of these two diseases. © 1971, American Medical Association. All rights reserved.